- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.03. | Pfizer CEO Albert Bourla collects $27.6M in 2025 pay following Metsera, MFN deals | ||
| 13.03. | FDA scolds CDMO Simtra with warning letter over contamination fumbles | ||
| 13.03. | 'Manufacturing is access': How Gilead's early production moves set PrEP med Yeztugo up for success | ||
| 13.03. | FDA fires off another manufacturing-related CRL, this one to Hyloris | ||
| 12.03. | Legend remains bullish on Carvykti growth despite threat from J&J's Tecvayli | ||
| 12.03. | After China outlay, Lilly plugs $126M into Japan manufacturing plant expansion | ||
| 12.03. | Eisai chooses 'Pokémon Sleep' app to battle bad sleep habits in awareness campaign | ||
| 12.03. | FDA rolls out new streamlined adverse event monitoring system, eyes $120M in savings | ||
| 12.03. | In latest compounding clash, Lilly flags high levels of 'impurity' in tirzepatide knockoffs with vitamin B12 | ||
| 12.03. | Rare disease drug sales to surge past $400B by 2032 despite FDA volatility: Evaluate report | ||
| 11.03. | As Lilly flourishes in Q4, peer projections signal looming sector slowdown in 2026 | ||
| 11.03. | AstraZeneca recruits Joshua Jackson, Philadelphia Flyers' Gritty to cancer screening push | ||
| 11.03. | Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement | ||
| 11.03. | Lilly beefs up oral GLP-1 capacity with $3B manufacturing pledge in China | ||
| 11.03. | UCB's Bimzelx continues winning streak with victory over AbbVie's Skyrizi | ||
| 11.03. | J&J's Joaquin Duato joins $30M CEO pay club with 30% compensation boost for 2025 | ||
| 11.03. | Skyhawk taps Teva alum to steer commercial path, while Santhera names new CCO to grow DMD sales | ||
| 10.03. | Sandoz to set up standalone biosimilars unit as it eyes upcoming 'golden decade' of patent losses | ||
| 10.03. | AbbVie's Robert Michael earns hefty pay bump to $32.5M in 2nd year as CEO | ||
| 10.03. | Patients want price transparency, e-commerce experience from pharma DTP platforms: survey | ||
| 10.03. | Novo Nordisk's US headquarters under fire in latest FDA warning letter | ||
| 10.03. | Leerink questions whether BioNTech can thrive without their 'founders' insight' as stock drops | ||
| 10.03. | Filana leaves Cassava Sciences roots behind amid branch into epilepsy | ||
| 10.03. | CSL telegraphs 300 new hires as it breaks ground on $1.5B plasma-based medicine plant near Chicago | ||
| 10.03. | FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.